rs1016792

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_005900.3(SMAD1):​c.1255-164C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.813 in 152,088 control chromosomes in the GnomAD database, including 51,198 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.81 ( 51198 hom., cov: 30)

Consequence

SMAD1
NM_005900.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.44

Publications

8 publications found
Variant links:
Genes affected
SMAD1 (HGNC:6767): (SMAD family member 1) The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Jul 2008]
SMAD1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 4-145557627-C-T is Benign according to our data. Variant chr4-145557627-C-T is described in ClinVar as Benign. ClinVar VariationId is 1227457.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.948 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMAD1NM_005900.3 linkc.1255-164C>T intron_variant Intron 6 of 6 ENST00000302085.9 NP_005891.1 Q15797-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMAD1ENST00000302085.9 linkc.1255-164C>T intron_variant Intron 6 of 6 1 NM_005900.3 ENSP00000305769.4 Q15797-1
SMAD1ENST00000394092.6 linkc.1255-164C>T intron_variant Intron 6 of 6 1 ENSP00000377652.2 Q15797-1
SMAD1ENST00000515385.1 linkc.1255-164C>T intron_variant Intron 6 of 6 2 ENSP00000426568.1 Q15797-1
SMAD1ENST00000511125.1 linkn.3005-164C>T intron_variant Intron 2 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.813
AC:
123586
AN:
151970
Hom.:
51147
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.956
Gnomad AMI
AF:
0.675
Gnomad AMR
AF:
0.637
Gnomad ASJ
AF:
0.760
Gnomad EAS
AF:
0.615
Gnomad SAS
AF:
0.763
Gnomad FIN
AF:
0.752
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.800
Gnomad OTH
AF:
0.785
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.813
AC:
123685
AN:
152088
Hom.:
51198
Cov.:
30
AF XY:
0.805
AC XY:
59804
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.956
AC:
39682
AN:
41514
American (AMR)
AF:
0.636
AC:
9720
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.760
AC:
2636
AN:
3470
East Asian (EAS)
AF:
0.615
AC:
3166
AN:
5146
South Asian (SAS)
AF:
0.763
AC:
3674
AN:
4818
European-Finnish (FIN)
AF:
0.752
AC:
7923
AN:
10542
Middle Eastern (MID)
AF:
0.759
AC:
223
AN:
294
European-Non Finnish (NFE)
AF:
0.800
AC:
54395
AN:
68000
Other (OTH)
AF:
0.783
AC:
1653
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1088
2175
3263
4350
5438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
876
1752
2628
3504
4380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.793
Hom.:
89918
Bravo
AF:
0.809
Asia WGS
AF:
0.695
AC:
2420
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.75
DANN
Benign
0.70
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1016792; hg19: chr4-146478779; API